Data automation is a critical need for pharmaceutical companies. The volume and diversity of data generated during the manufacturing process has exploded. Automated digitization of data is essential to accessing and analyzing this valuable data.
This whitepaper introduces data automation and its capabilities, and examines the current regulatory environment as it relates to the implementation of data automation solutions. It highlights three key strategies companies can use to realize the benefits of data automation without sacrificing compliance or security.